logo
welcome
Science News

Science News

A new drug shows promise for hot flashes due to menopause

Science News
Summary
Nutrition label

84% Informative

Two phase 3 clinical trials compared the drug elinzanetant with a placebo at two timepoints.

The drug subdued hot flashes quickly: By the fourth week , a majority of those taking the drug reported at least a 50 percent reduction in frequency.

By the 12-week mark, more than 70 percent of those who took the drug experienced a drop in hot flash frequency.

Participants on the drug also reported significantly improved sleep compared with those on placebo.

There is a 52-week trial of elinzanetant assessing longer-term safety.

Another trial is looking at how well the drug works for women receiving therapy for hormone-positive breast cancer.

Many women experiencing hot flashes and other bothersome symptoms of menopause are n’t getting sufficient or appropriate treatment.

VR Score

87

Informative language

89

Neutral language

44

Article tone

semi-formal

Language

English

Language complexity

60

Offensive language

likely offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

long-living

Affiliate links

no affiliate links